Vulolisib
Vulolisib is a potent, orally bioavailable pan-PI3K inhibitor with low nanomolar IC50 values, showing particular selectivity for the PI3Kα isoform. It demonstrates anti-proliferative effects in cancer cell lines and has been investigated in preclinical in vivo models for oncology research, highlighting its utility in studying PI3K pathway dysregulation.
Product Specifications
CAS Number
2390105-79-8
Field of Research
Signal Transduction
Smiles
N ([C@H] (C (N) =O) C) C=1C=C2C (C=3N (C=C (N3) N4[C@H] ([C@H] (F) F) CSC4=O) CCO2) =CC1
Molecular Formula
C18H19F2N5O3S
Molecular Weight
423.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx307318-01 20 µg
COX19, Cytochrome C Oxidase Assembly Factor (COX19) Antibody (FITC)
Sign In for Pricing
View Details abx307318-02 50 µg
COX19, Cytochrome C Oxidase Assembly Factor (COX19) Antibody (FITC)
Sign In for Pricing
View Details abx307318-03 100 µg
COX19, Cytochrome C Oxidase Assembly Factor (COX19) Antibody (FITC)
Sign In for Pricing
View Details abx307318-04 200 µg
COX19, Cytochrome C Oxidase Assembly Factor (COX19) Antibody (FITC)
Sign In for Pricing
View Details